Abbott fends off challenge to patent (Chicago Tribune)

Abbott fends off challenge to patent (Chicago Tribune)
Abbott Laboratories won a court ruling that ends a generic-drug company’s challenge to the Canadian patent for the antibiotic Biaxin XL.